近十余年来免疫学有了很大进展,阐明了一些过去认为病因不明疾病的发病机理,并为其防治提供了新的途径。在矽肺病变过程中,病人的细胞免疫状态是否会受到影响,可否作为矽肺病人临床疗效判断、药物筛选的一种客观指标,为此,对重钢耐火厂各期矽肺病人的T细胞和B细胞作了检测研究。 Nearly 10 years of immunology has made great progress, clarified some of the past that the etiology of disease pathogenesis, and provide a new way for its prevention and treatment. In the process of silicosis, whether the patient’s cellular immune status will be affected, whether it can be used as an objective indicator of clinical efficacy and drug screening in patients with silicosis, for this reason, T cells and B cells Made a test study.